ResultsIQ

ResultsIQ › Latest results › Capillary Technologies India Limited

Capillary Technologies India Limited strategy deck summary

NSE: CAPILLARY · BSE: 544614

Strategy deck of 24 Feb 2026, summarised by AI from the filing.

Capillary acquires Session M for $20M base consideration, targeting FY30 adjusted EBITDA ~₹398 cr.

Key takeaways

  1. Acquisition Capillary acquires Session M for a base consideration of $20M, subject to customary closing adjustments, providing access to $35Mn+ revenue.
  2. Guidance Projected FY30 adjusted EBITDA ~₹398 cr; 20%+ organic annual growth rate; 45%+ free cash flow; ROIC of 20%+.
  3. Change Two acquisitions in FY26 - Kognitiv and Session M - with approximately 60 customers to be integrated over 24-36 months.
  4. Risk Integration of acquired customers onto Capillary's platform may take 24-36 months.

Original filing on BSE

Capillary Technologies India Limited Q1 FY27 results

As filed: Revenue ₹257 cr, EBITDA ₹40.3 cr, PAT −₹9.6 cr, EBITDA margin 15.7%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹257 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹191 cr, EBITDA ₹31.4 cr, PAT ₹43.4 cr, EBITDA margin 16.4%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹191 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −11.8% in 30 days (Nifty 500: −0.5%).
  • Q3 FY26: Revenue ₹184 cr, EBITDA ₹25.0 cr, PAT ₹8.0 cr, EBITDA margin 13.6%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹184 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −14.7% in 28 days (Nifty 500: −4.0%).

Past price moves after results do not indicate future moves. Not a recommendation.

Capillary Technologies India Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.